Form 4: Gilead Officer Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Gilead Sciences' Chief Communications Officer, Johanna Mercier, sold 3,000 shares of GILD common stock at $144.23 per share.

Summary

  • Johanna Mercier, Chief Communications & Corporate Affairs Officer of Gilead Sciences, Inc. (GILD), reported the sale of 3,000 shares of common stock.
  • The transaction occurred on March 16, 2026, at a price of $144.23 per share.
  • Following this sale, Johanna Mercier directly beneficially owns 131,779 shares of Gilead Sciences common stock.
  • The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted on February 20, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which typically reflects personal financial management rather than a change in company fundamentals.

Negatives

  • Johanna Mercier, Chief Communications & Corporate Affairs Officer, sold 3,000 shares of common stock, which some investors may interpret as a minor negative signal, although the sale was pre-scheduled under a 10b5-1 plan.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 trading plans are a common practice among corporate executives. These plans allow insiders to pre-arrange sales of company stock at a future date, providing an affirmative defense against claims of trading on material non-public information. Such transactions are generally viewed as part of an executive's personal financial planning and diversification strategy, rather than a direct reflection of their immediate outlook on the company's performance.

Stakeholder Impact

  • Shareholders: Minor impact due to a routine, pre-scheduled insider transaction that is unlikely to significantly influence the company's stock price or perceived value.

Key Dates

DateDescription
02/20/2025Date Rule 10b5-1 trading plan was adopted by Johanna Mercier.
03/16/2026Date of common stock transaction (sale of 3,000 shares).
03/17/2026Date the Form 4 was signed.

Keywords

Gilead Sciences, GILD, Insider Sale, Form 4, 10b5-1 Plan, Johanna Mercier, Stock Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.